OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Generation of Gene Therapies as the Future of Wet AMD Treatment
Janusz Błasiak, Elżbieta Pawłowska, Justyna Ciupińska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2386-2386
Open Access | Times Cited: 10

Showing 10 citing articles:

Genetic Insights into Age-Related Macular Degeneration
Bhumika, Nalini S. Bora, Puran S. Bora
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1479-1479
Open Access | Times Cited: 9

Co-delivery of antioxidants and siRNA-VEGF: promising treatment for age-related macular degeneration
Marina França Dias, Estael Luzia Coelho da Cruz-Cazarim, Frederico Pittella, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 1

Age-Related Macular Degeneration (AMD): Pathophysiology, Drug Targeting Approaches, and Recent Developments in Nanotherapeutics
Mahendra Pratap Singh, Riyakshi Negi, Alka, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1647-1647
Open Access | Times Cited: 5

Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration
S. W. Tang, Jiaqi Yang, Bowen Xiao, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 12, pp. 20-20
Open Access | Times Cited: 4

Age-Related Macular Degeneration Pathophysiology and Therapeutic Potential of Tocotrienols: An Update
Muhammad Zulfiqah Sadikan, Lidawani Lambuk, Nur Hidayah Reshidan, et al.
Journal of Ocular Pharmacology and Therapeutics (2025)
Closed Access

Tackling visual impairment: emerging avenues in ophthalmology
Fang Lin, Yuxing Su, Chenxi Zhao, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access

Evaluating TAB2, IKBKB, and IKBKG Gene Polymorphisms and Serum Protein Levels and Their Association with Age-Related Macular Degeneration and Its Treatment Efficiency
Alvita Vilkevičiūtė, Enrika Pileckaitė, Akvile Bruzaite, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2072-2072
Open Access | Times Cited: 1

Stakeholder insights on cost, quality, and incorporating patient voice in managed care decisions on neovascular (wet) age-related macular degeneration: Findings from the AMCP Market Insights program
Bridget Flavin, Andrew M. Schimel, Zachary Contreras, et al.
Journal of Managed Care & Specialty Pharmacy (2024) Vol. 30, Iss. 11-a Suppl, pp. S1-S9
Closed Access

A Cascading Approach with Vision Transformers for Age-Related Macular Degeneration Diagnosis and Explainability
Ainhoa Osa-Sanchez, Hossam Magdy Balaha, Mahmoud Ali, et al.
Lecture notes in computer science (2024), pp. 250-265
Closed Access

Updates on Gene Therapy for Neovascular Age-related Macular Degeneration: A Review
A. Sharma, Nilesh Kumar
EyeQuest (2024) Vol. 49, Iss. 1, pp. 3-12
Closed Access

Page 1

Scroll to top